Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alexandra C. Racanelli
Therapeutics by Cytotoxic Metabolite Accumulation: Pemetrexed Causes ZMP Accumulation, AMPK Activation, and Mammalian Target of Rapamycin Inhibition
Cancer Research
Cancer Research
Oncology
Related publications
Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids
European Oncology and Haematology
Oncology
Hematology
Systemic Inhibition of Mammalian Target of Rapamycin Inhibits Fear Memory Reconsolidation
Neurobiology of Learning and Memory
Cognitive Psychology
Behavioral Neuroscience
Experimental
Cognitive Neuroscience
Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by OncogenicK-ras
Cancer Research
Cancer Research
Oncology
Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy
Current Neurology and Neuroscience Reports
Neuroscience
Neurology
Chronic Inhibition of Mammalian Target of Rapamycin by Rapamycin Modulates Cognitive and Non-Cognitive Components of Behavior Throughout Lifespan in Mice
Neuroscience
Neuroscience
Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte Differentiation
Journal of Neuroscience
Neuroscience
Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)
Science-Business eXchange
Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging
Annals of the American Thoracic Society
Pulmonary
Respiratory Medicine
